These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17934492)

  • 1. p27: tumor suppressor and oncogene ...?
    Kossatz U; Malek NP
    Cell Res; 2007 Oct; 17(10):832-3. PubMed ID: 17934492
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment to the 2004 World Health Organization classification of pituitary tumors.
    Saeger W
    Acta Neuropathol; 2006 Jan; 111(1):64-5. PubMed ID: 16328525
    [No Abstract]   [Full Text] [Related]  

  • 3. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
    Polyak K
    Cancer Cell; 2006 Nov; 10(5):352-4. PubMed ID: 17097557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
    Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
    Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway.
    Li X; Cai L; Liang M; Wang Y; Yang J; Zhao Y
    Anat Rec (Hoboken); 2008 May; 291(5):593-600. PubMed ID: 18399550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p27Kip1: tumor suppressor and oncogene?].
    Besson A
    Med Sci (Paris); 2007 Dec; 23(12):1089-91. PubMed ID: 18154709
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer: Kip moving.
    Collard JG
    Nature; 2004 Apr; 428(6984):705-8. PubMed ID: 15085115
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
    Chu IM; Hengst L; Slingerland JM
    Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21(WAF1/CIP1) and cancer: a shifting paradigm?
    Gartel AL
    Biofactors; 2009; 35(2):161-4. PubMed ID: 19449443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
    Sun X; Zhang HW; Zhang ZR
    J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene addiction and non-oncogene addiction in glioblastoma therapy.
    Ng K; Chen CC
    Chin Med J (Engl); 2011 Sep; 124(17):2565-8. PubMed ID: 22040404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic diagnosis and therapy of head and neck cancer].
    Otsuki N; Nibu K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1126-31. PubMed ID: 18686364
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel p27 gene mutation in a case of unclassified myeloproliferative disorder.
    Pappa V; Papageorgiou S; Papageorgiou E; Panani A; Boutou E; Tsirigotis P; Dervenoulas J; Economopoulos T; Raptis S
    Leuk Res; 2005 Feb; 29(2):229-31. PubMed ID: 15607373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duality of p27Kip1 function in tumorigenesis.
    Sicinski P; Zacharek S; Kim C
    Genes Dev; 2007 Jul; 21(14):1703-6. PubMed ID: 17639075
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrant methylation in promoter regions of cyclin-dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary gland.
    Daa T; Kashima K; Kondo Y; Yada N; Suzuki M; Yokoyama S
    APMIS; 2008 Jan; 116(1):21-6. PubMed ID: 18254776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic alterations and genetic diagnosis of human cancer].
    Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1711-5. PubMed ID: 9279103
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
    Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
    Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers.
    Yamanaka K; Mizuarai S; Eguchi T; Itadani H; Hirai H; Kotani H
    Genomics; 2009 Oct; 94(4):219-27. PubMed ID: 19559782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.